Guillén VS

Language: Spanish
References: 10
Page: 179-182
PDF size: 949.5 Kb.

ABSTRACT

In this article we present a 66 year old male patient with inflammatory bowel disease who developed a thromboembolic event. We explain how the development of thromboembolic events in patients with inflammatory bowel disease is common and almost always occurs in this type of patients in a active phase of the disease; In addition to the importance of knowing this possible pathology it is explain its physiopathology, diagnosis and treatment.

REFERENCES

1. Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res. 15 de abril de 1996; 82(2):137- 46.

2. Guerra Montero LJ, Ingver A, Casañas A, Sosa C, Iade B. Clinical characteristics of patients with inflammatory bowel disease and thromboembolic events. Acta Gastroenterol Latinoam. Junio de 2010; 40(2):134-41.

3. Koutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, et al. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol. Noviembre de 2004;16(11):1147-52.

4. López Morante AJ, Prieto García M, Yuguero del Mora L, Sáez-Royuela F, Martín Lorente JL, Ojeda Giménez C. Coagulation changes in inflammatory intestinal disease. Rev Clínica Española. Enero de 1992;190(1):18- 21.

5. Magro F, Dinis – Ribeiro M, Araújo FM, Pereira P, Fraga MC, Cunha – Ribeiro LM, et al. High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. Noviembre de 2003;15(11):1157-63.

6. Scaldaferri F, Lancellotti S, Pizzoferrato M, De Cristofaro R. Haemostatis system in inflammatory bowel diseases: new players in gut inflammation. World J Gastroenterol WJG. Febrero de 2011;17(5):594- 608.

7. Sundaram KK, Cotton R, Hart P, Jones L, Gould SR. Laboratory findings associated with thrombophilia are not more common in inflammatory bowel disease. Clin Lab Haematol. Agosto de 2000;22(4):243-5.

8. Van Bodegraven AA. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterol Suppl. 2003;(239):51-62.

9. Yilmaz S, Bayan K, Tüzün Y, Batun S, Altintas A. A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis. Diciembre de 2006;22(3):205-12.

10. Yurekli BPS, Aksoy DY, Aybar M, Egesel T, Gurgey A, Hascelik G, et al. The search for a common thrombophilic state during the active state of inflammatory bowel disease. Eur J Gastroenterol. Octubre de 2006;40(9):809-13.